112 related articles for article (PubMed ID: 23345300)
1. An unusual cause of false-positive results with the BD GeneOhm Cdiff assay.
Louie L; Wong H; Mubareka S; Simor AE
J Clin Microbiol; 2013 Apr; 51(4):1348-9. PubMed ID: 23345300
[No Abstract] [Full Text] [Related]
2. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
Shin BM; Mun SJ; Yoo SJ; Kuak EY
J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
[TBL] [Abstract][Full Text] [Related]
4. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
[TBL] [Abstract][Full Text] [Related]
6. Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency.
Munson E; Bilbo D; Paul M; Napierala M; Hryciuk JE
J Clin Microbiol; 2011 Jun; 49(6):2279-82. PubMed ID: 21450967
[TBL] [Abstract][Full Text] [Related]
7. Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.
Kok J; Wang Q; Thomas LC; Gilbert GL
J Clin Microbiol; 2011 Oct; 49(10):3719-21. PubMed ID: 21849697
[No Abstract] [Full Text] [Related]
8. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
Kvach EJ; Ferguson D; Riska PF; Landry ML
J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
[TBL] [Abstract][Full Text] [Related]
9. Targeting the tcdA gene: is this appropriate for detection of A and/or B Clostridium difficile toxin-producing strains?
Kozak K; Elagin V; Norén T; Unemo M
J Clin Microbiol; 2011 Jun; 49(6):2383; author reply 2383-4. PubMed ID: 21617002
[No Abstract] [Full Text] [Related]
10. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
Dalpke AH; Hofko M; Zorn M; Zimmermann S
J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of Simplexa universal direct and BD GeneOhm tests for detection of toxigenic Clostridium difficile in stool samples.
Nolte FS; Ribeiro-Nesbitt DG
J Clin Microbiol; 2014 Jan; 52(1):281-2. PubMed ID: 24197886
[TBL] [Abstract][Full Text] [Related]
12. Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.
Barbut F; Monot M; Rousseau A; Cavelot S; Simon T; Burghoffer B; Lalande V; Tankovic J; Petit JC; Dupuy B; Eckert C
Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1279-85. PubMed ID: 21487764
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.
Lalande V; Barrault L; Wadel S; Eckert C; Petit JC; Barbut F
J Clin Microbiol; 2011 Jul; 49(7):2714-6. PubMed ID: 21525213
[TBL] [Abstract][Full Text] [Related]
14. Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.
Hirvonen JJ; Kaukoranta SS
Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):1005-9. PubMed ID: 25616552
[TBL] [Abstract][Full Text] [Related]
15. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces.
Terhes G; Urbán E; Sóki J; Nacsa E; Nagy E
J Clin Microbiol; 2009 Nov; 47(11):3478-81. PubMed ID: 19794052
[TBL] [Abstract][Full Text] [Related]
17. Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.
Stellrecht KA; Espino AA; Maceira VP; Nattanmai SM; Butt SA; Wroblewski D; Hannett GE; Musser KA
J Clin Microbiol; 2014 May; 52(5):1423-8. PubMed ID: 24554744
[TBL] [Abstract][Full Text] [Related]
18. To the Editor: Molecular epidemiology of toxigenic Clostridium difficile isolates in Korea.
Cho SY; Nam Y; Soh YS; Park TS; Lee HJ
Epidemiol Infect; 2014 Aug; 142(8):1651-2. PubMed ID: 24290036
[No Abstract] [Full Text] [Related]
19. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
Deak E; Miller SA; Humphries RM
J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
